~~<i id='AED1572B9F'><strike id='AED1572B9F'><tt id='AED1572B9F'><pre id='AED1572B9F'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

knowledge

author：leisure time 2025-08-12 11:29:56 - browse：37532

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

LONDON — Novo Nordisk said Monday it would acquire the German firm Cardior Pharmaceuticals in a deal worth up to $1.1 billion, picking up additional drug candidates for its pipeline of cardiometabolic medicines.

Cardior focuses on targeting RNA to address the root causes of heart disease. Its lead candidate, known CDR132L, is in Phase 2 development as a treatment for health failure.

The companies did not disclose how much Novo was paying upfront for Cardior and how much would be based on future milestones being achieved. The deal is expected to close in the second quarter.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban
Next article： Ohioans vote in high

hotspot

Wikipedia

hotspot

Wikipedia

hotspot

FILE-MembersgroupbearinginsigniasofthewhitesupremacistPatriotFrontshoveCharlesMurrellwithmetalshield

WSS

Biden praises World Series champion Astros for impact off the field during White House celebration

‘The Bear’ and hospitality in hospitals

H5N1 communication has been strictly for the birds

Ohioans vote in high

Judge rejects Trump's counterclaim against E. Jean Carroll

Bird flu outbreak in cows is latest avian flu curveball

explore

knowledge

hotspot

Moonlake's readout produced a cash windfall. Risks remain

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

Sports medicine is finally prioritizing gender equality

Wegovy cuts risk of cardiovascular events by 20%, study finds

Sports medicine is finally prioritizing gender equality

Discs beat pads, tampons for heavy menstrual flow, new study shows

Supreme Court strikes down use of affirmative action

Researchers on aging grapple with how to calculate biological age

Medicare details structure of new drug price negotiation program

Medicare says breakthrough device reimbursement rule to come by summer

Wikipedia

Making AI in medicine accessible to smaller, and rural hospitals

Medicare says breakthrough device reimbursement rule to come by summer

What nurses really want: sufficient staffing for patient care

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Judge rejects Trump's counterclaim against E. Jean Carroll

hotspot

Wikipedia

hotspot

hotspot